We're Not Building Another Menopause App—We're Enhancing Yours with Emotional Intelligence (EI) AI

A Single Data Point Sparked Our Mission!

Millions of women suffer silently because menopause is underdiagnosed, misunderstood, and often mismanaged — costing lives, careers, and billions.

The menopause market is experiencing unprecedented growth, with companies developing innovative solutions across hormone therapy, symptom management, diagnostic tools, and wellness products. Yet despite this innovation, women are still falling through the cracks. The missing piece isn't more products—it's intelligent technology that can enhance existing solutions and eliminate diagnostic bias.

Why the Menopause Sector Needs EI + AI Integration

The numbers tell a compelling story for businesses in this space:r businesses in this space:

Market Opportunity: The global menopause market is projected to reach $24.4 billion by 2030, driven by increasing awareness and an aging population.

Diagnostic Gap: 75% of women experience menopause symptoms, yet 25% are never properly diagnosed by their healthcare providers.

Competitive Pressure: "Companies with superior diagnostic accuracy and personalised treatment approaches will capture market share from those relying on traditional methods"

Regulatory Trends: Healthcare systems are increasingly demanding evidence-based solutions with measurable outcomes, exactly what AI provides.

AICogniTech's Partnership Vision

Rather than build another standalone product, we're seeking strategic partnerships with established menopause-focused companies. We are building an EI AI Agent technology that can be customised and integrated into your existing products and services, enhancing their effectiveness and treatment results.

The Technology Integration Advantage

Emotional Intelligence Integration: Unlike purely clinical AI, our technology will understand the emotional complexity of menopause, facilitating better patient engagement and compliance. The AI Agents are constructed through sector-specific and in-depth AI-EI Q&As and built according to medical-topic-sector language, terminology and medical records data.

Pattern Recognition: Advanced algorithms will identify subtle symptom correlations that enhance diagnostic accuracy and treatment optimisation or recommendations.

NOTE: Bias Elimination: Objective analysis counters the medical gaslighting that affects 29% of menopausal women.

Real-Time Adaptation: Continuous learning from patient outcomes will improve your EI-AI performance over time, such as a 'learning curve'!

Partnership Benefits: Beyond Technology

Competitive Differentiation: Be the first in your sector to offer EI-AI-enhanced menopause solutions.

Improved Outcomes: Measurable gains in diagnostic accuracy, patient satisfaction, and treatment relevance — driven by EI-AI-powered personalisation. Result: Authentic services, stronger patient trust, and long-term loyalty.

Market Expansion: Access new customer segments through enhanced product capabilities.

Regulatory Advantage: Demonstrate evidence-based outcomes that meet evolving healthcare standards.

Revenue Growth: Premium pricing for AI-enhanced solutions with proven superior results.

Investment and Commitment

This partnership model requires mutual investment. AICogniTech provides the AI technology, development resources, expert development guidance and ongoing support. Partners provide market expertise, customer access, and co-investment in development costs.

Partners Criteria - and Personal Invitation

We're seeking companies that share our mission:

Market Leadership: Established brands with significant menopause market presence. Innovation Culture: Organisations committed to advancing women's health through technology. Customer Focus: Companies prioritising patient outcomes over pure profit

Growth Mindset: Partners ready to invest in next-generation solutions Values Alignment: Organizations committed to eliminating healthcare bias

The women in our lives deserve better than the current standard of menopause care. The question isn't whether EI AI will transform menopause care—it's whether your company will lead that transformation.

Partnership Inquiries: 📧 contact@aicognitech.com 📞 Schedule a call: https://whereby.com/aicognitech Cebuan de La Rochette Founder & CEO, AICogniTech

‍